Back to Results
First PageMeta Content
Piperazines / Breakthrough therapy / Nintedanib / Boehringer Ingelheim / Kasumigaseki / Adverse effect / Ministry of Health /  Labour /  and Welfare / Package insert


Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio
Add to Reading List

Document Date: 2016-08-04 23:26:02


Open Document

File Size: 74,51 KB

Share Result on Facebook